Financial Review: Envista (NYSE:NVST) versus Lancer Orthodontics (OTCMKTS:LANZ)

Envista (NYSE:NVST) and Lancer Orthodontics (OTCMKTS:LANZ) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk.

Valuation & Earnings

This table compares Envista and Lancer Orthodontics”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.57 billion	1.37	-$100.20 million	($7.77)	-2.62
Lancer Orthodontics	N/A	N/A	N/A	N/A	N/A

Lancer Orthodontics has lower revenue, but higher earnings than Envista.

Profitability

This table compares Envista and Lancer Orthodontics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envista	-53.42%	3.76%	2.24%
Lancer Orthodontics	N/A	N/A	N/A

Volatility and Risk

Envista has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, Lancer Orthodontics has a beta of 1.71, meaning that its stock price is 71% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Envista and Lancer Orthodontics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	1	11	3	0	2.13
Lancer Orthodontics	0	0	0	0	0.00

Envista currently has a consensus target price of $20.71, indicating a potential upside of 1.56%. Given Envista’s stronger consensus rating and higher possible upside, equities analysts clearly believe Envista is more favorable than Lancer Orthodontics.

Summary

Envista beats Lancer Orthodontics on 6 of the 8 factors compared between the two stocks.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

About Lancer Orthodontics

Lancer Orthodontics, Inc. designs, manufactures, and markets orthodontic products for orthodontists and dentists worldwide. It offers aesthetic brackets, brackets and buccal tubes, bands, adhesives, wires, elastomerics, intraoral and extraoral appliances, instruments, and miscellaneous products. The company was founded in 1967 and is based in Vista, California.